United States · FDA National Drug Code directory

EXXUA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
23594-151_5694dd0b-7231-c5ba-e063-6394a90a9621
Product NDC
23594-151
Form
TABLET, EXTENDED RELEASE
Composition / generic term
gepirone
Labeler
Aytu Therapeutics, LLC
Marketing category
NDA
Marketing start / end (source format)
20251001
Source listing expiry
20271231

Source-listed ingredients

  • GEPIRONE HYDROCHLORIDE — 36.3 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (23594-151-30) · 23594-151-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →